Company intelligence / Profile preview

InfuScience

Gurnee, Illinois, United States

Ownership: Private
Development stage: Other

Overview

InfuScience operated specialty infusion services for acute and chronically ill patients but faced significant regulatory compliance issues. The FDA issued a warning letter in December 2020 documenting serious deficiencies in sterile drug product manufacturing practices, including inadequate aseptic processing controls, facility design violations, and personnel monitoring failures[5].

Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on InfuScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InfuScience.

Explore the full profile